Note 17 - Income Taxes - Deferred Tax Assets (Details) - USD ($) $ in Thousands |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Notes To Financial Statements [Abstract] | ||
| Net operating losses carried forward | $ 87,938 | $ 79,951 |
| Research and development expenditures | 5,023 | 5,016 |
| Property, equipment, and other intangible assets | 7,265 | 7,265 |
| Research and development tax credits | 4,822 | 4,864 |
| Financing costs | 718 | 909 |
| Restricted interest and financing expenses | 202 | 0 |
| Right-of-use assets | 5 | 13 |
| Total deferred tax assets | 105,973 | 98,018 |
| Valuation allowance | (105,973) | (98,018) |
| Net deferred tax asset | $ 0 | $ 0 |
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from undeducted financing costs. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, equipment, and other intangible assets. No definition available.
|
| X | ||||||||||
- Definition Deferred tax assets restricted interest and financing expenses. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from right-of-use assets. No definition available.
|
| X | ||||||||||
- Definition Notes To Financial Statements Abstract No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|